Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 12:10:goac032.
doi: 10.1093/gastro/goac032. eCollection 2022.

Efficacy and safety of low-dose thalidomide combined with mesalazine in the treatment of refractory ulcerative colitis in adults

Jun-Rong Chen  1 , Lei Mai  2 , Jia-Chen Sun  3 , Xiang Peng  4 , Min Zhang  4 , Min Zhi  4
Affiliations

Efficacy and safety of low-dose thalidomide combined with mesalazine in the treatment of refractory ulcerative colitis in adults

Jun-Rong Chen et al. Gastroenterol Rep (Oxf). .
No abstract available

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
The flowchart of low-dose thalidomide combined with mesalazine for adult patients with refractory ulcerative colitis
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Ordás I, Eckmann L, Talamini M. et al. Ulcerative colitis. Lancet 2012;380:1606–19. - PubMed
    1. Singh S, Chowdhry M, Umar S. et al. Variations in the medical treatment of inflammatory bowel disease among gastroenterologists. Gastroenterol Rep (Oxf) 2018;6:61–4. - PMC - PubMed
    1. Puzik A, Thiel A, Faust K. et al. Thalidomide has anti-inflammatory properties in neonatal immune cells. Innate Immun 2013;19:42–52. - PubMed
    1. Peng X, Zhi M, Wei M. et al. Thalidomide results in diminished ovarian reserve in reproductive age female IBD patients. Medicine (Baltimore) 2017;96:e6540. - PMC - PubMed
    1. Turner D, Ruemmele FM, Orlanski-Meyer E. et al. Management of paediatric ulcerative colitis, part 1: ambulatory care-an evidence-based guideline from European Crohn’s and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2018;67:257–91. - PubMed